派博傳思國際中心

標(biāo)題: Titlebook: Clinical Ophthalmic Oncology; Uveal Tumors Bertil E. Damato,Arun D. Singh Book 2019Latest edition Springer Nature Switzerland AG 2019 Cance [打印本頁]

作者: BRISK    時間: 2025-3-21 16:14
書目名稱Clinical Ophthalmic Oncology影響因子(影響力)




書目名稱Clinical Ophthalmic Oncology影響因子(影響力)學(xué)科排名




書目名稱Clinical Ophthalmic Oncology網(wǎng)絡(luò)公開度




書目名稱Clinical Ophthalmic Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Clinical Ophthalmic Oncology被引頻次




書目名稱Clinical Ophthalmic Oncology被引頻次學(xué)科排名




書目名稱Clinical Ophthalmic Oncology年度引用




書目名稱Clinical Ophthalmic Oncology年度引用學(xué)科排名




書目名稱Clinical Ophthalmic Oncology讀者反饋




書目名稱Clinical Ophthalmic Oncology讀者反饋學(xué)科排名





作者: Narcissist    時間: 2025-3-21 21:23
Uveal Melanoma: Resection Techniques,. These operations can be undertaken as primary procedures, with or without neoadjuvant radiotherapy, or they can be performed as treatment for exudative and neovascular complications (i.e., ‘toxic tumor syndrome’).
作者: paleolithic    時間: 2025-3-22 03:05

作者: Substitution    時間: 2025-3-22 08:23
978-3-030-17881-9Springer Nature Switzerland AG 2019
作者: CRUMB    時間: 2025-3-22 10:08

作者: cavity    時間: 2025-3-22 13:29
http://image.papertrans.cn/c/image/228131.jpg
作者: cavity    時間: 2025-3-22 17:18

作者: AMEND    時間: 2025-3-23 01:05
Anna-Marie Metz,Heinz-Jürgen Rothe. These operations can be undertaken as primary procedures, with or without neoadjuvant radiotherapy, or they can be performed as treatment for exudative and neovascular complications (i.e., ‘toxic tumor syndrome’).
作者: crumble    時間: 2025-3-23 02:14

作者: 極端的正確性    時間: 2025-3-23 06:52
Andrew Marshall,Sreedhar Natarajan the process of defining different tumor classes and correlating these with each other in a logical manner based on the putative cell of origin. Classification also involves “grading” of tumor cell morphological features and consideration of their immunohistochemical and genetic profiles. It does no
作者: 口訣    時間: 2025-3-23 10:42

作者: Capitulate    時間: 2025-3-23 16:10

作者: ALOFT    時間: 2025-3-23 18:46
Andrew Marshall,Sreedhar Natarajaned, which includes localization of the lesion within the various ocular tissues, identification of secondary effects in adjacent tissues, expert interpretation of imaging studies, and, in selected cases, tumor biopsy. The author has devised the mnemonic “MOLES” to distinguish choroidal nevi from mel
作者: 極力證明    時間: 2025-3-24 00:12
https://doi.org/10.1007/b100866 molecules that can be targeted using systemic therapies. Most UM have . initiating mutations, which activate the MAPK pathway, with dysregulation of the PI3K/AKT and other signaling pathways. Some patients develop UM because they have inherited the . tumor predisposition syndrome, which also causes
作者: 有組織    時間: 2025-3-24 04:23

作者: 斷斷續(xù)續(xù)    時間: 2025-3-24 10:21

作者: Trigger-Point    時間: 2025-3-24 12:04
Een saaie plek kiezen voor de time-out145–152, 1930). This technique was later modified by Stallard and eventually further refined using radioactive plaques containing cobalt-60 anchored to the episcleral surface (Stallard, Br J Ophthalmol 32(9):618–639, 1948; Stallard, Br J Ophthalmol 50(3):147–155, 1966). In the United States, this ra
作者: 常到    時間: 2025-3-24 16:21

作者: 600    時間: 2025-3-24 22:41
Werken met punten, fiches en contracten at the target tissue with relatively little irradiation of surrounding healthy tissues. There are two techniques of delivering stereotactic radiation to the eye: stereotactic radiosurgery and fractionated stereotactic radiotherapy. Stereotactic radiosurgery (SRS) involves multiple radiation beams t
作者: 誘惑    時間: 2025-3-25 01:07
https://doi.org/10.1007/978-90-313-6882-2ereas others such as photocoagulation are important for historical context. AU-011 is a novel photosensitizing agent which has shown some promise for treating smaller melanomas. In general, phototherapy of uveal melanomas is less reliable than radiotherapy and is therefore not widely deployed as pri
作者: 直言不諱    時間: 2025-3-25 06:36

作者: 左右連貫    時間: 2025-3-25 08:04
SPA - Screening psychischer Arbeitsbelastungfrom 1986 until 1998, with clinical follow-up continuing until 2003. It was a multicentered study comprised of 43 participating clinical centers in North America with centralized units dealing with echography (North Carolina), photography (Iowa), pathology (Wisconsin), radiation physics (Texas), and
作者: Kidnap    時間: 2025-3-25 11:50

作者: Meager    時間: 2025-3-25 16:48

作者: Sedative    時間: 2025-3-25 23:11
Andrew Marshall,Sreedhar NatarajanThe clinical presentation of uveal melanoma is influenced by its site of origin (iris, ciliary body, or choroid), pigmentation, size and shape, the extent of any secondary retinal detachment, and presence of a hemorrhage, inflammation, or any extrascleral extension.
作者: BLANC    時間: 2025-3-26 01:19
Andrew Marshall,Sreedhar NatarajanUveal melanomas develop from melanocytes that reside within the stroma of the choroid, ciliary body, and iris. No basement membrane is breached when the tumor develops.
作者: HARD    時間: 2025-3-26 07:53

作者: 治愈    時間: 2025-3-26 11:56
Uveal Melanoma: Clinical Features,The clinical presentation of uveal melanoma is influenced by its site of origin (iris, ciliary body, or choroid), pigmentation, size and shape, the extent of any secondary retinal detachment, and presence of a hemorrhage, inflammation, or any extrascleral extension.
作者: 斑駁    時間: 2025-3-26 13:30
Uveal Melanoma: Histopathologic Features,Uveal melanomas develop from melanocytes that reside within the stroma of the choroid, ciliary body, and iris. No basement membrane is breached when the tumor develops.
作者: indignant    時間: 2025-3-26 16:50

作者: jettison    時間: 2025-3-27 00:23

作者: Wallow    時間: 2025-3-27 05:06
Andrew Marshall,Sreedhar Natarajanwhom visual loss is irreversible if long-standing. This chapter highlights procedures that are specific to the assessment of a patient with a uveal tumor. It is assumed that a full ophthalmic and systemic history is routinely obtained in all patients in addition to clinically relevant ancillary investigations.
作者: 單挑    時間: 2025-3-27 06:43

作者: 支架    時間: 2025-3-27 11:21

作者: Glycogen    時間: 2025-3-27 14:36

作者: molest    時間: 2025-3-27 18:02
Uveal Tumors: Examination Techniques,whom visual loss is irreversible if long-standing. This chapter highlights procedures that are specific to the assessment of a patient with a uveal tumor. It is assumed that a full ophthalmic and systemic history is routinely obtained in all patients in addition to clinically relevant ancillary investigations.
作者: 軌道    時間: 2025-3-28 00:38
Classification of Uveal Tumors,ification also involves “grading” of tumor cell morphological features and consideration of their immunohistochemical and genetic profiles. It does not include tumor “staging,” which determines the extent of tumor involvement and hence the type of treatment required (i.e., local versus systemic treatment).
作者: 寒冷    時間: 2025-3-28 05:08
Benign Melanocytic Tumors of the Uvea,tes are derived from neural crest and share this embryologic origin with cutaneous melanocytes. This chapter describes iris, ciliary body, and choroidal nevi as well as oculo(dermal) melanocytosis and melanocytoma, which are considered as variants of nevus.
作者: Slit-Lamp    時間: 2025-3-28 09:46

作者: MAIM    時間: 2025-3-28 10:59
Andrew Marshall,Sreedhar Natarajananomas according to mushroom shape, orange pigment, large tumor size, enlargement, and subretinal fluid. The author has also developed an online atlas (.) to enable diagnosis of ocular tumors according to their color and location.
作者: 嘴唇可修剪    時間: 2025-3-28 17:24

作者: LAVA    時間: 2025-3-28 21:19

作者: 不利    時間: 2025-3-29 00:46
Iris Melanoma,ncisional biopsy, excisional biopsy, or radiotherapy depending upon the size, extent, and visual potential. Iris melanomas tend to be less aggressive in comparison to melanomas in other uveal locations.
作者: Rheumatologist    時間: 2025-3-29 05:20

作者: 容易懂得    時間: 2025-3-29 10:20

作者: 財產(chǎn)    時間: 2025-3-29 14:13
Book 2019Latest editionosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book is divided into six volumes: Basic Principles, Eyelid and Conjunctival Tumors, O
作者: 虛假    時間: 2025-3-29 19:02
Uveal Tumors: Examination Techniques,astectomy has been performed. The duration of the visual loss can have prognostic significance, for example, in patients with choroidal hemangioma in whom visual loss is irreversible if long-standing. This chapter highlights procedures that are specific to the assessment of a patient with a uveal tu
作者: 圍巾    時間: 2025-3-29 23:22
Classification of Uveal Tumors, the process of defining different tumor classes and correlating these with each other in a logical manner based on the putative cell of origin. Classification also involves “grading” of tumor cell morphological features and consideration of their immunohistochemical and genetic profiles. It does no
作者: 仔細(xì)閱讀    時間: 2025-3-30 03:09

作者: 使苦惱    時間: 2025-3-30 04:42
Uveal Melanoma: Epidemiologic Aspects,elanoma in the United States is similar to that in European countries. The overall mean incidence of uveal melanoma in the United States is 5.2 per million per year with a higher rate in males (6.0 per million per year) as compared to females (4.5 per million per year). Uveal melanoma is more common
作者: DIKE    時間: 2025-3-30 09:14

作者: instructive    時間: 2025-3-30 13:00
Uveal Melanoma: Molecular Pathology, molecules that can be targeted using systemic therapies. Most UM have . initiating mutations, which activate the MAPK pathway, with dysregulation of the PI3K/AKT and other signaling pathways. Some patients develop UM because they have inherited the . tumor predisposition syndrome, which also causes
作者: Camouflage    時間: 2025-3-30 17:19

作者: parallelism    時間: 2025-3-31 00:35

作者: ADORE    時間: 2025-3-31 04:06
Uveal Melanoma: Brachytherapy,145–152, 1930). This technique was later modified by Stallard and eventually further refined using radioactive plaques containing cobalt-60 anchored to the episcleral surface (Stallard, Br J Ophthalmol 32(9):618–639, 1948; Stallard, Br J Ophthalmol 50(3):147–155, 1966). In the United States, this ra
作者: 炸壞    時間: 2025-3-31 08:28
Uveal Melanoma: Proton Beam Radiation Therapy,ith heavy charged particles, such as protons, are used to treat most choroidal and ciliary body tumors, and high rates of local control are achieved with both modalities. However, highly localized and uniform dose distributions can be delivered with proton beam radiotherapy, which makes it particula
作者: linear    時間: 2025-3-31 12:46
Uveal Melanoma: Stereotactic Radiation Therapy, at the target tissue with relatively little irradiation of surrounding healthy tissues. There are two techniques of delivering stereotactic radiation to the eye: stereotactic radiosurgery and fractionated stereotactic radiotherapy. Stereotactic radiosurgery (SRS) involves multiple radiation beams t
作者: LUT    時間: 2025-3-31 15:52
Uveal Melanoma: Phototherapy,ereas others such as photocoagulation are important for historical context. AU-011 is a novel photosensitizing agent which has shown some promise for treating smaller melanomas. In general, phototherapy of uveal melanomas is less reliable than radiotherapy and is therefore not widely deployed as pri
作者: Itinerant    時間: 2025-3-31 21:18
Uveal Melanoma: Resection Techniques,. These operations can be undertaken as primary procedures, with or without neoadjuvant radiotherapy, or they can be performed as treatment for exudative and neovascular complications (i.e., ‘toxic tumor syndrome’).
作者: 胰島素    時間: 2025-4-1 00:11

作者: Tdd526    時間: 2025-4-1 03:31

作者: Resection    時間: 2025-4-1 09:23
Uveal Melanoma: Prognostication Methods,nly rarely respond to treatment so that most patients die within a year of onset of symptoms. There are hopes that systemic adjuvant therapy may delay or prevent metastatic disease. This requires targeting of high-risk patients, according to anatomic, histologic, and genetic predictors. Metastatic d
作者: 接合    時間: 2025-4-1 13:51
Uveal Melanoma: Epidemiologic Aspects, malignant mesothelioma, meningioma, and lung adenocarcinoma. In the large majority of cases, the etiology is unknown, although ocular melanomas are most common in fair individuals with light-colored eyes.
作者: induct    時間: 2025-4-1 15:05

作者: 熔巖    時間: 2025-4-1 19:50
Animal Models in Uveal Melanoma,is and immunology, tumor dormancy, metastasis, liquid biopsy, and treatment strategies. Many attempts have been made to create optimal models that mimic UM biology, disease course and metastasis, but challenges remain in imitating the genetic, histologic, immunologic, and metastatic features of UM.
作者: 緩解    時間: 2025-4-2 01:01

作者: Intact    時間: 2025-4-2 03:49
Uveal Melanoma: Proton Beam Radiation Therapy,ity observed in patients who undergo enucleation or receive radiotherapy. Currently there are no effective treatments for metastatic uveal melanoma, which develops in the liver in most cases. Further research to discover new therapies and preventive strategies is necessary to improve survival.
作者: Colonnade    時間: 2025-4-2 09:11





歡迎光臨 派博傳思國際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
根河市| 东宁县| 光山县| 城固县| 石首市| 堆龙德庆县| 张家川| 泌阳县| 南岸区| 象山县| 罗田县| 辰溪县| 金乡县| 广德县| 鹤庆县| 岳阳县| 即墨市| 昌平区| 绥江县| 江阴市| 哈密市| 栖霞市| 麻江县| 佳木斯市| 库车县| 上虞市| 比如县| 永寿县| 黑山县| 迁西县| 淮滨县| 道孚县| 米林县| 芜湖县| 江油市| 大埔区| 平舆县| 新密市| 公安县| 大庆市| 顺义区|